AB2 Bio Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $21.1M
Latest Deal Amount
  • Investors
  • 1

AB2 Bio General Information

Description

Drug developers for inflammation-based diseases. The company develops treatments and medicines for inflammatory and autoimmune diseases.

Contact Information

Website
www.ab2bio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
  • EPFL Innovation Park
  • Building B, 4th Floor
  • 1015 Lausanne
  • Switzerland
+41 021 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AB2 Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 14-Jan-2016 $21.1M 000.00 Completed Generating Revenue
2. Accelerator/Incubator 000.00 Completed Startup
1. Early Stage VC $30.1M $30.1M Completed Startup
To view AB2 Bio’s complete valuation and funding history, request access »

AB2 Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Drug developers for inflammation-based diseases. The company develops treatments and medicines for inflammatory and auto
Drug Discovery
Lausanne, Switzerland
000.00
0000000000 0 000.00

000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
0000 000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00

00000000

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000 000000000
Houston, TX
00 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AB2 Bio Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kineta Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
00000000 000000000 Formerly VC-backed Houston, TX 00 00000 000000000 - 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 Venture Capital-Backed Diepenbeek, Belgium 0 000.00 000000 - 000 000.00
0000 000000000000 Venture Capital-Backed Oxford, United Kingdom 000 00000 00000000000 00000
To view AB2 Bio’s complete competitors history, request access »

AB2 Bio Executive Team (6)

Name Title Board Seat Contact Info
Fernando Cunha Chief Financial Officer
Djordje Filipovic Ph.D Chief Commercial Officer
Barthélemy Helg Co-Founder & Board of Director
You’re viewing 3 of 6 executive team members. Get the full list »

AB2 Bio Board Members (5)

Name Representing Role Since
Andrea Pfeifer Ph.D Self Chairwoman 000 0000
Barthélemy Helg AB2 Bio Co-Founder & Board of Director 000 0000
Bénédict Hentsch AB2 Bio Board Member 000 0000
Erich Hunziker Ph.D Self Board Member 000 0000
Gerald Cagle Ph.D AB2 Bio Board Member 000 0000
To view AB2 Bio’s complete board members history, request access »

AB2 Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EPFL Innovation Park Accelerator/Incubator 000 0000 000000 0
To view AB2 Bio’s complete investors history, request access »